
Prevalence of High-Risk Human Papillomavirus (HPV) among Negative Visual Inspection of Acetic Acid (VIA)
Author(s) -
Tofan Widya Utami,
M. F. Aziz,
Gatot Purwoto,
Alexander Peters,
Gert Jan Fleuren,
Vivian Spaan,
Sigit Purbadi
Publication year - 2016
Publication title -
indonesian journal of obstetrics and gynecology
Language(s) - English
Resource type - Journals
eISSN - 2338-7335
pISSN - 2338-6401
DOI - 10.32771/inajog.v2i3.398
Subject(s) - genotype , medicine , cervical cancer , human papillomavirus , hpv infection , virology , cancer , biology , gene , genetics
Objective: Persistence of high-risk HPV infection is known to be the
major cause of cervical cancer. It is important to differentiate the
genotype of HPV infection, whether it is high, intermediate or low
risk. The aim of this study was to assess the prevalence of high-risk
HPV types among Indonesian women with negative VIA.
Method: We analyzed cervical swabs from 1,214 patients with negative
VIA. By using INNO-Lipa HPV DNA test, we detected the HPV
DNA and its genotype.
Result: From the 1,214 women with negative VIA, 48 (3.95%) samples
were confirmed to have positive HPV DNA by using PCR and
electrophoresis. However, hybridization test were not able to detect
HPV genotypes in 9 samples. These 9 samples were tested again
with PCR and electrophoresis and resulted in negative HPV DNA.
Among the remaining 39 samples (3.21%), we detected 19 types of
HPV, consisting of 13 types of high-risk HPV, 5 types of low-risk HPV,
and 1 type of unknown HPV (type X).
Conclusion: Among patients with negative VIA, 3.21% was found to
be positive for HPV DNA. From this percentage, the prevalence of
high-risk HPV is higher than the low-risk and unknown HPV. Therefore
we cannot ignore results of negative VIA, particularly in highrisk
group, because there is a slight possibility that presence of HPV
can be identified, especially the high risk ones which have a tendency
to be persistent. We support the importance of HPV DNA test
as cervical cancer screening method.
[Indones J Obstet Gynecol 2014; 3: 153-156]
Keywords: cervical cancer, high-risk HPV, negative VIA